Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2001 1
2002 1
2003 1
2005 1
2006 1
2007 7
2008 5
2009 7
2010 7
2011 6
2012 5
2013 1
2014 1
2015 1
2017 1
2018 1
2020 1
2021 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Predictive Factors of the Use of Rituximab and Belimumab in Spanish Lupus Patients.
Capdevila O, Mitjavila F, Espinosa G, Caminal-Montero L, Marín-Ballvè A, González León R, Castro A, Canora J, Pinilla B, Fonseca E, Ruiz-Irastorza G; RELES, Autoimmune Diseases Study Group (GEAS), Spanish Society of Internal Medicine. Capdevila O, et al. Medicina (Kaunas). 2023 Jul 25;59(8):1362. doi: 10.3390/medicina59081362. Medicina (Kaunas). 2023. PMID: 37629652 Free PMC article.
The value of repeat biopsy in lupus nephritis flares.
Narváez J, Ricse M, Gomà M, Mitjavila F, Fulladosa X, Capdevila O, Torras J, Juanola X, Pujol-Farriols R, Nolla JM. Narváez J, et al. Among authors: capdevila o. Medicine (Baltimore). 2017 Jun;96(24):e7099. doi: 10.1097/MD.0000000000007099. Medicine (Baltimore). 2017. PMID: 28614228 Free PMC article. Review.
Pragmatic, open-label, single-center, randomized, phase II clinical trial to evaluate the efficacy and safety of methylprednisolone pulses and tacrolimus in patients with severe pneumonia secondary to COVID-19: The TACROVID trial protocol.
Solanich X, Antolí A, Padullés N, Fanlo-Maresma M, Iriarte A, Mitjavila F, Capdevila O, Molina M, Sabater J, Bas J, Mensa-Vilaró A, Niubó J, Calvo N, Bolivar S, Rigo-Bonnin R, Arregui L, Tebé C, Hereu P, Videla S, Corbella X. Solanich X, et al. Among authors: capdevila o. Contemp Clin Trials Commun. 2021 Mar;21:100716. doi: 10.1016/j.conctc.2021.100716. Epub 2021 Jan 19. Contemp Clin Trials Commun. 2021. PMID: 33495742 Free PMC article. Review.
Treatment options for resistant pneumococcal infections.
Pallares R, Capdevila O, Grau I. Pallares R, et al. Among authors: capdevila o. Clin Microbiol Infect. 1999 Aug;5 Suppl 4:S3-S11. doi: 10.1111/j.1469-0691.1999.tb00851.x. Clin Microbiol Infect. 1999. PMID: 11869278 Free article. No abstract available.
[Intermediate care unit of internal medicine].
Riera A, Capdevila O, Formiga F, Máñez R, Pujol R. Riera A, et al. Among authors: capdevila o. Rev Clin Esp. 2007 Oct;207(9):479-80; author reoly 480-1. doi: 10.1157/13109848. Rev Clin Esp. 2007. PMID: 17915178 Spanish. No abstract available.
Beneficial effect of corticosteroids in preventing mortality in patients receiving tocilizumab to treat severe COVID-19 illness.
Rubio-Rivas M, Ronda M, Padulles A, Mitjavila F, Riera-Mestre A, García-Forero C, Iriarte A, Mora JM, Padulles N, Gonzalez M, Solanich X, Gasa M, Suarez-Cuartin G, Sabater J, Perez-Fernandez XL, Santacana E, Leiva E, Ariza-Sole A, Dallaglio PD, Quero M, Soriano A, Pasqualetto A, Koo M, Esteve V, Antoli A, Moreno-Gonzalez R, Yun S, Cerda P, Llaberia M, Formiga F, Fanlo M, Montero A, Chivite D, Capdevila O, Bolao F, Pinto X, Llop J, Sabate A, Guardiola J, Cruzado JM, Comin-Colet J, Santos S, Jodar R, Corbella X. Rubio-Rivas M, et al. Among authors: capdevila o. Int J Infect Dis. 2020 Dec;101:290-297. doi: 10.1016/j.ijid.2020.09.1486. Epub 2020 Oct 6. Int J Infect Dis. 2020. PMID: 33035673 Free PMC article.
45 results